Repositorio Dspace

Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study

Mostrar el registro sencillo del ítem

dc.contributor.author Palma-Carbajal, Ricardo
dc.contributor.author Belahnech, Yassin
dc.contributor.author de-la-Torre-Hernández, José-María
dc.contributor.author Camarero, Tamara-García
dc.contributor.author Vegas-Valle, José-Miguel
dc.contributor.author Murillo, Juan-Rondan
dc.contributor.author Gómez-Menchero, Antonio
dc.contributor.author Pérez-de-Prado, Armando
dc.contributor.author Pinar-Bermúdez, Eduardo
dc.contributor.author Martín-Lorenzo, Pedro
dc.contributor.author Jiménez-Mazuecos, Jesus-Manuel
dc.contributor.author García-San-Román, Koldobika
dc.contributor.author Vaquerizo, Beatriz
dc.contributor.author Calviño-Santos, Ramón
dc.contributor.author Lozano-Ruiz-Poveda, Fernando
dc.contributor.author Ojeda-Pineda, Soledad
dc.contributor.author Perea-Armijo, Jorge
dc.contributor.author Bayon, Jeremias
dc.contributor.author Goicolea-RuiGómez, Javier
dc.contributor.author Briales, Juan-H-Alonso
dc.contributor.author Sanchis, Juan
dc.contributor.author García-del-Blanco, Bruno
dc.date.accessioned 2026-08-03T10:28:50Z
dc.date.available 2026-08-03T10:28:50Z
dc.date.issued 2026-03-31
dc.identifier.issn 1756-1477
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/27123
dc.description.abstract BACKGROUND: Percutaneous coronary intervention (PCI) for complex anatomy is increasingly common. The third-generation Ultimaster TANSEI drug-eluting stent (DES) was developed to optimise safety and efficacy in challenging lesions. METHODS: This was a prospective, single-arm, multicentre registry (August 2020-November 2022) of patients with complex lesions - left main, bifurcations, small vessels and long lesions - treated with Ultimaster TANSEI DES and followed for 1 year. The primary endpoint was the device-oriented composite endpoint (DoCE), including cardiac death, target-vessel MI, target-vessel revascularisation (TVR) and stent thrombosis. The secondary endpoint was the patient-oriented composite endpoint (PoCE), including all-cause death, any MI and any revascularisation. RESULTS: In total, 501 patients with 591 complex lesions (mean age 66.7 years; 79.6% male; 33.4% with diabetes) were treated. Lesion types: left main 11%, bifurcations 43.9%, small vessels 40.7%, long lesions 34.3%. At 1 year, incidence rates were: DoCE 3.23 per 100 person-years (95% CI [1.84-5.24]) and PoCE 5.04 per 100 person-years (95% CI [3.26-7.44]). In subgroup analyses, long lesions (>35 mm) showed consistently higher risk: DoCE RR 4.22 (95% CI [1.49-11.95]; p=0.006), PoCE RR 4.93 ([2.10-11.57]; p<0.001), overall mortality RR 4.79 [1.53-15.06]; p=0.007) and TVR RR 17.60 [2.22-139.51]; p<0.001).
dc.language.iso eng
dc.publisher RADCLIFFE CARDIOLOGY
dc.rights Atribución/Reconocimiento-NoComercial 4.0 Internacional 
dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/deed.es  *
dc.title Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 42003940
dc.relation.publisherversion https://www.icrjournal.com/articleindex/icr.2025.33
dc.type.version info:eu-repo/semantics/publishedVersion 
dc.identifier.doi 10.15420/icr.2025.33
dc.journal.title INTERVENTIONAL CARDIOLOGY-REVIEWS RESEARCH RESOURCES
dc.identifier.essn 1756-1485


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial 4.0 Internacional  Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial 4.0 Internacional 

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta